Cargando…

The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada

INTRODUCTION: Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast cancer diagnosis and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arneja, Jasleen, Brooks, Jennifer D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389459/
https://www.ncbi.nlm.nih.gov/pubmed/34437611
http://dx.doi.org/10.1371/journal.pone.0256536
_version_ 1783742865337221120
author Arneja, Jasleen
Brooks, Jennifer D.
author_facet Arneja, Jasleen
Brooks, Jennifer D.
author_sort Arneja, Jasleen
collection PubMed
description INTRODUCTION: Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast cancer diagnosis and treatment. METHODS: Women with a personal history of breast cancer (N = 3,372) were identified from the cross-sectional Canadian Partnership Against Cancer (CPAC) Experiences of Cancer Patients in Transitions Survey. Multinomial (nominal) logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the relationship between burden of comorbidities and overall QOL and emotional health (very poor/poor, fair, good, very good). RESULTS: Of the 3,372 participants, 57% reported at least one chronic condition at the time of breast cancer diagnosis. As the number of chronic conditions at diagnosis increased, the odds of reporting worse quality of life and emotional health following treatment also increased. Specifically, compared to women reporting very good QOL, for each additional chronic condition, women reported significantly higher odds of reporting good (OR = 1.22, 95% CI: 1.12, 1.32), fair (OR = 1.76, 95% CI: 1.58, 1.96), or poor/very poor (OR = 2.31, 95% CI: 1.86, 2.88) QOL. Similarly, for each additional comorbidity, women reported significantly higher odds of reporting good (OR = 1.17, 95% CI: 1.07, 1.28), fair (OR = 1.63, 95% CI: 1.46, 1.82), or poor/very poor (OR = 2.17, 95% CI: 1.81, 2.60) emotional health, relative to very good emotional health. CONCLUSION: Breast cancer survivors coping with a high comorbidity burden experience worse overall QOL and emotional health following treatment. This highlights the importance of integrating information on comorbidities into survivorship care to improve the experience and overall outcomes of patients with complex needs.
format Online
Article
Text
id pubmed-8389459
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83894592021-08-27 The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada Arneja, Jasleen Brooks, Jennifer D. PLoS One Research Article INTRODUCTION: Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast cancer diagnosis and treatment. METHODS: Women with a personal history of breast cancer (N = 3,372) were identified from the cross-sectional Canadian Partnership Against Cancer (CPAC) Experiences of Cancer Patients in Transitions Survey. Multinomial (nominal) logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the relationship between burden of comorbidities and overall QOL and emotional health (very poor/poor, fair, good, very good). RESULTS: Of the 3,372 participants, 57% reported at least one chronic condition at the time of breast cancer diagnosis. As the number of chronic conditions at diagnosis increased, the odds of reporting worse quality of life and emotional health following treatment also increased. Specifically, compared to women reporting very good QOL, for each additional chronic condition, women reported significantly higher odds of reporting good (OR = 1.22, 95% CI: 1.12, 1.32), fair (OR = 1.76, 95% CI: 1.58, 1.96), or poor/very poor (OR = 2.31, 95% CI: 1.86, 2.88) QOL. Similarly, for each additional comorbidity, women reported significantly higher odds of reporting good (OR = 1.17, 95% CI: 1.07, 1.28), fair (OR = 1.63, 95% CI: 1.46, 1.82), or poor/very poor (OR = 2.17, 95% CI: 1.81, 2.60) emotional health, relative to very good emotional health. CONCLUSION: Breast cancer survivors coping with a high comorbidity burden experience worse overall QOL and emotional health following treatment. This highlights the importance of integrating information on comorbidities into survivorship care to improve the experience and overall outcomes of patients with complex needs. Public Library of Science 2021-08-26 /pmc/articles/PMC8389459/ /pubmed/34437611 http://dx.doi.org/10.1371/journal.pone.0256536 Text en © 2021 Arneja, Brooks https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Arneja, Jasleen
Brooks, Jennifer D.
The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title_full The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title_fullStr The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title_full_unstemmed The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title_short The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada
title_sort impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in canada
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389459/
https://www.ncbi.nlm.nih.gov/pubmed/34437611
http://dx.doi.org/10.1371/journal.pone.0256536
work_keys_str_mv AT arnejajasleen theimpactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada
AT brooksjenniferd theimpactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada
AT arnejajasleen impactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada
AT brooksjenniferd impactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada